Abusharekh Mohammed, Kampf Jürgen, Dykun Iryna, Backmann Viktoria, Jánosi Rolf Alexander, Totzeck Matthias, Rassaf Tienush, Mahabadi Amir Abbas
Department of Cardiology and Vascular Medicine, The West German Heart and Vascular Center Essen, University Hospital Essen, 45147, Essen, Germany.
Int J Cardiol Cardiovasc Risk Prev. 2024 Sep 27;23:200336. doi: 10.1016/j.ijcrp.2024.200336. eCollection 2024 Dec.
Smoking has conflicting results on outcomes following acute myocardial infarction (AMI). We evaluated the independent influence of smoking status on patient outcomes.
We included patients with AMI undergoing invasive coronary angiography with available self-reported smoking status. The incidence of death of any cause was evaluated during a median follow-up of 1.14 years (range 0.36-3.40 years). Association between smoking status and long-term mortality was evaluated using multivariable adjusted Cox regression analysis.
From 1612 AMI patients (aged 65.7 ± 13.3 years, 72.1 % male), 378 patients (23.4 %) were current-smokers, 311 (19.3 %) ex-smokers, and 923 (57.3 %) non-smokers. Compared with non-smokers, current-smokers were younger (68.5 ± 13.0 vs. 58.6 ± 12.5, p < 0.0001) and more frequently presented with STEMI (21.6 % vs. 35,4 %, p < 0.0001), while ex-smokers with similar frequency of STEMI-manifestation as non-smokers (22.5 %, p = 0.79) constituted an intermediate-group in terms of age (65.8 ± 11,6 years). Although smoking status was not significantly associated with long-term survival in unadjusted-analysis, active-smokers had 56 % higher long-term mortality than non-smokers when adjusting for age, gender, medications and other traditional risk factors, whereas ex-smokers possessed comparable survival probability (current-smokers: 1.56[1.14-2.14], p = 0.006, ex-smokers 1.16[0.84-1.59], p = 0.37). Current-smokers had unadjusted lower NT-proBNP and modestly higher absolute in-hospital left ventricular global longitudinal strain (LV GLS) values that did not differ among groups after the same adjustments (NT-proBNP: -0.08[-0.31; 0.15], p = 0.5, LV GLS: 0.65[-0.26; 1.55], p = 0.16).
Active smoking is associated with increased adjusted long-term mortality, earlier onset and more frequent manifestation as STEMI, compared to non-smoking. Comparable adjusted results for LV GLS and NT-proBNP between groups support the presence of the pseudoparadox.
吸烟对急性心肌梗死(AMI)后的预后影响存在矛盾的结果。我们评估了吸烟状态对患者预后的独立影响。
我们纳入了接受有创冠状动脉造影且有自我报告吸烟状态的AMI患者。在中位随访1.14年(范围0.36 - 3.40年)期间评估任何原因导致的死亡发生率。使用多变量调整的Cox回归分析评估吸烟状态与长期死亡率之间的关联。
在1612例AMI患者(年龄65.7±13.3岁,72.1%为男性)中,378例患者(23.4%)为当前吸烟者,311例(19.3%)为既往吸烟者,923例(57.3%)为非吸烟者。与非吸烟者相比,当前吸烟者更年轻(68.5±13.0岁对58.6±12.5岁,p<0.0001),且更频繁地表现为ST段抬高型心肌梗死(STEMI)(21.6%对35.4%,p<0.0001),而既往吸烟者STEMI表现频率与非吸烟者相似(22.5%,p = 0.79),在年龄方面构成中间组(65.8±11.6岁)。尽管在未调整分析中吸烟状态与长期生存无显著关联,但在调整年龄、性别、药物和其他传统危险因素后,当前吸烟者的长期死亡率比非吸烟者高56%,而既往吸烟者的生存概率相当(当前吸烟者:1.56[1.14 - 2.14],p = 0.006,既往吸烟者1.16[0.84 - 1.59],p = 0.37)。当前吸烟者未调整的N末端脑钠肽前体(NT-proBNP)较低,住院期间左心室整体纵向应变(LV GLS)绝对值略高,在相同调整后各组间无差异(NT-proBNP:-0.08[-0.31;0.15],p = 0.5,LV GLS:0.65[-0.26;1.55],p = 0.16)。
与不吸烟相比,当前吸烟与调整后的长期死亡率增加、STEMI发病更早且表现更频繁相关。各组间LV GLS和NT-proBNP的调整结果相当,支持假性矛盾现象的存在。